Annouschka Laenen

7.7k total citations · 1 hit paper
304 papers, 4.6k citations indexed

About

Annouschka Laenen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Annouschka Laenen has authored 304 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pulmonary and Respiratory Medicine, 75 papers in Oncology and 72 papers in Surgery. Recurrent topics in Annouschka Laenen's work include Breast Cancer Treatment Studies (46 papers), Head and Neck Cancer Studies (21 papers) and Breast Lesions and Carcinomas (21 papers). Annouschka Laenen is often cited by papers focused on Breast Cancer Treatment Studies (46 papers), Head and Neck Cancer Studies (21 papers) and Breast Lesions and Carcinomas (21 papers). Annouschka Laenen collaborates with scholars based in Belgium, United States and Netherlands. Annouschka Laenen's co-authors include Hans Wildiers, Patrick Neven, Geert Molenberghs, Tony Vangeneugden, Chantal Mathieu, Ignace Vergote, Caroline Weltens, Geert Maleux, Ann Smeets and Helena Geys and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Annouschka Laenen

274 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial

2024 55 citations Katrien Benhalima, Dominique Ballaux et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annouschka Laenen Belgium	37	1.2k	1.1k	833	793	668	304	4.6k
Ramin Sadeghi Iran	40	1.4k 1.2×	814 0.8×	513 0.6×	965 1.2×	465 0.7×	298	4.9k
Noriyuki Katsumata Japan	38	1.2k 1.0×	2.8k 2.6×	990 1.2×	811 1.0×	708 1.1×	183	5.7k
Marc Botteman United States	36	1.3k 1.1×	1.2k 1.1×	291 0.3×	899 1.1×	223 0.3×	212	5.5k
Mimi Kim United States	48	515 0.4×	972 0.9×	452 0.5×	536 0.7×	487 0.7×	195	7.7k
Sander M. J. van Kuijk Netherlands	36	2.0k 1.7×	486 0.4×	886 1.1×	602 0.8×	337 0.5×	433	5.6k
Christian Dehlendorff Denmark	39	1.1k 0.9×	1.0k 0.9×	278 0.3×	565 0.7×	842 1.3×	152	4.7k
R. Bergström Sweden	43	974 0.8×	1.9k 1.7×	388 0.5×	841 1.1×	457 0.7×	110	5.3k
Gregg Nelson Canada	42	4.4k 3.8×	1.0k 0.9×	987 1.2×	588 0.7×	199 0.3×	190	7.7k
William P. Tew United States	44	1.5k 1.3×	3.3k 3.0×	990 1.2×	1.6k 2.1×	694 1.0×	217	9.3k
Angela Chetrit Israel	38	609 0.5×	772 0.7×	289 0.3×	330 0.4×	326 0.5×	131	4.3k

Countries citing papers authored by Annouschka Laenen

Since Specialization

Citations

This map shows the geographic impact of Annouschka Laenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annouschka Laenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annouschka Laenen more than expected).

Fields of papers citing papers by Annouschka Laenen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annouschka Laenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annouschka Laenen. The network helps show where Annouschka Laenen may publish in the future.

Co-authorship network of co-authors of Annouschka Laenen

This figure shows the co-authorship network connecting the top 25 collaborators of Annouschka Laenen. A scholar is included among the top collaborators of Annouschka Laenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annouschka Laenen. Annouschka Laenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ballaux, Dominique, Gerd Vanhaverbeke, Youri Taes, et al.. (2025). Cost-effectiveness of advanced hybrid closed loop therapy compared to standard insulin therapy for type 1 diabetes in pregnancy: an economic evaluation of the CRISTAL trial. EClinicalMedicine. 81. 103106–103106. 2 indexed citations

Peeters, Marc, Dominique Ballaux, Gerd Vanhaverbeke, et al.. (2025). Who Benefits Most from Advanced Hybrid Closed Loop Therapy in Pregnancy Across Different Subgroups: A Secondary Analysis of the Randomized Controlled CRISTAL Trial. Diabetes Technology & Therapeutics. 28(3). 253–263.

Laenen, Annouschka, Jeroen Dekervel, Diethard Monbaliu, et al.. (2025). Long-Term Outcome of Liver Transplantation for Hepatocellular Carcinoma After Bridging or Downstaging with Doxorubicin-Eluting Superabsorbent Polymer Microspheres. CardioVascular and Interventional Radiology. 48(4). 472–484.

Laenen, Annouschka, et al.. (2024). The effectiveness of an individualised and adaptive game-based rehabilitation, iVision, on visual perception in cerebral visual impairment: A triple-blind randomised controlled trial. Research in Developmental Disabilities. 156. 104899–104899. 1 indexed citations

Deroose, Christophe M., Chris Verslype, Diethard Monbaliu, et al.. (2024). Resin-Based Yttrium-90 Radioembolization as a Bridging or Downstaging Treatment to Liver Transplantation for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 36(2). 282–292. 2 indexed citations

Pauwels, Elin, Timon Vandamme, Willem Lybaert, et al.. (2024). Clinical impact of using [ ¹⁸ F ] AlF ‐ NOTA ‐octreotide PET / CT instead of [ ⁶⁸ Ga ]Ga‐ DOTA ‐ SSA PET / CT : Secondary endpoint analysis of a multicenter, prospective trial. Journal of Neuroendocrinology. 36(8). e13420–e13420. 4 indexed citations

Nissen, Peter H., Frede Donskov, Agnieszka Woźniak, et al.. (2024). Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism. Clinical Genitourinary Cancer. 22(5). 102180–102180. 1 indexed citations

Laenen, Annouschka, Machteld Keupers, Ines Nevelsteen, et al.. (2024). Expression patterns of H3K27me3 for differentiation of breast fibroadenomas and phyllodes tumors. Apmis. 133(1). e13485–e13485. 2 indexed citations

Wu, Qi, Barbara Brouwers, Bruna Dalmasso, et al.. (2022). Dynamic alterations of immunosenescence-related genes in older women with breast cancer receiving chemotherapy: A prospective study. Translational Oncology. 25. 101527–101527. 5 indexed citations

10.

Baekelandt, Jan, Chantal Mathieu, Annouschka Laenen, et al.. (2021). Adnexectomy by vaginal Natural Orifice Transluminal Endoscopic Surgery versus laparoscopy: results of a first randomised controlled trial (NOTABLE trial). BJOG An International Journal of Obstetrics & Gynaecology. 128(11). 1782–1791. 41 indexed citations

11.

Verdonck, Anna, et al.. (2021). Self-Esteem and Oral Health-Related Quality of Life within a Cleft Lip and/or Palate Population: A Prospective Cohort Study. International Journal of Environmental Research and Public Health. 18(11). 6078–6078. 7 indexed citations

12.

Kinget, Lisa, Eduard Roussel, Annelies Verbiest, et al.. (2021). MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma. Cancers. 13(12). 3099–3099. 19 indexed citations

13.

Tambuyzer, Tim, Krizia Tuand, Victoria Depoorter, et al.. (2020). A Systematic Review of Estimating Breast Cancer Recurrence at the Population Level With Administrative Data. JNCI Journal of the National Cancer Institute. 112(10). 979–988. 24 indexed citations

14.

Willems, Guy, et al.. (2020). Dental development in patients with and without unilateral cleft lip and palate (UCLP): a case control study. Clinical Oral Investigations. 25(5). 2619–2631. 7 indexed citations

15.

Nuland, Marc Van, Sibyl Anthierens, Kris Van den Broeck, et al.. (2020). Effectiveness of a blended care programme for the discontinuation of benzodiazepine use for sleeping problems in primary care: study protocol of a cluster randomised trial, the Big Bird trial. BMJ Open. 10(2). e033688–e033688. 7 indexed citations

16.

Kindts, I., Annouschka Laenen, Stéphanie Peeters, et al.. (2016). Validation of the Web-Based IBTR! 2.0 Nomogram to Predict for Ipsilateral Breast Tumor Recurrence After Breast-Conserving Therapy. International Journal of Radiation Oncology*Biology*Physics. 95(5). 1477–1484. 10 indexed citations

17.

Baert, Thaïs, Annouschka Laenen, Ahmad Kasran, et al.. (2015). IMMUNOSUPPRESSIVE PARAMETERS IN SERUM OF OVARIAN CANCER PATIENTS CHANGE DURING THE DISEASE COURSE. International Journal of Gynecological Cancer. 401. 1 indexed citations

18.

Smeets, Ann, Barbara Brouwers, Sigrid Hatse, et al.. (2013). Circulating CCL5 Levels in Patients with Breast Cancer: Is There a Correlation with Lymph Node Metastasis?. Lirias (KU Leuven). 2013. 1–5. 8 indexed citations

19.

Hatse, Sigrid, Diether Lambrechts, Annemieke Verstuyf, et al.. (2011). Low 25-hydroxyvitamin d3 serum levels are associated with larger breast tumor size. Annals of Oncology. 22. 60–60. 2 indexed citations

20.

Laenen, Annouschka & Ariel Alonso. (2010). The Functional Living Index-Cancer: estimating its reliability based on clinical trial data. Quality of Life Research. 19(1). 103–109. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact